Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -5.21% | 161.91 | 0.0% | $1387.78m | |
| NVAX | Novavax, Inc. | -2.57% | 221.50 | 80.0% | $650.79m | |
| AMGN | Amgen, Inc. | 0.10% | 255.97 | 1.3% | $554.37m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -5.63% | 7.55 | 0.7% | $527.77m | |
| ILMN | Illumina, Inc. | 1.30% | 404.18 | 3.5% | $527.33m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.58% | 499.69 | 2.7% | $447.00m | |
| GILD | Gilead Sciences, Inc. | -1.38% | 65.95 | 1.0% | $437.06m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.10% | 219.18 | 1.9% | $383.57m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.09% | 165.47 | 2.0% | $360.29m | |
| BNTX | BioNTech SE | -1.36% | 149.48 | 0.0% | $336.51m | |
| BIIB | Biogen, Inc. | -0.47% | 269.05 | 1.7% | $246.78m | |
| NBIX | Neurocrine Biosciences, Inc. | -1.79% | 94.85 | 4.9% | $180.78m | |
| EXAS | EXACT Sciences Corp. | -1.93% | 127.53 | 18.4% | $168.47m | |
| CRSP | CRISPR Therapeutics AG | -2.97% | 115.04 | 0.6% | $158.56m | |
| SGEN | Seagen Inc. | -1.02% | 144.01 | 5.8% | $140.14m |
Company Profile
Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.